Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.

Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Meijer GA, Fijneman RJ.

Cell Oncol (Dordr). 2012 Aug;35(4):293-300. doi: 10.1007/s13402-012-0088-2. Epub 2012 Jun 19.

PMID:
22711543
2.

TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.

Sillars-Hardebol AH, Carvalho B, Tijssen M, Beliën JA, de Wit M, Delis-van Diemen PM, Pontén F, van de Wiel MA, Fijneman RJ, Meijer GA.

Gut. 2012 Nov;61(11):1568-75. Epub 2011 Dec 29.

PMID:
22207630
3.

BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain.

Sillars-Hardebol AH, Carvalho B, Beliën JA, de Wit M, Delis-van Diemen PM, Tijssen M, van de Wiel MA, Pontén F, Fijneman RJ, Meijer GA.

J Pathol. 2012 Feb;226(3):442-50. doi: 10.1002/path.2983. Epub 2011 Oct 18.

PMID:
22009326
4.

Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.

Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MA, van Criekinge W, Thas O, Matthäi A, Cuesta MA, Terhaar Sive Droste JS, Craanen M, Schröck E, Ylstra B, Meijer GA.

Gut. 2009 Jan;58(1):79-89. doi: 10.1136/gut.2007.143065. Epub 2008 Oct 1.

PMID:
18829976
5.

Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.

Pimiento JM, Neill KG, Henderson-Jackson E, Eschrich SA, Chen DT, Husain K, Shibata D, Coppola D, Malafa MP.

Am J Pathol. 2016 Oct;186(10):2761-8. doi: 10.1016/j.ajpath.2016.06.016. Epub 2016 Aug 10.

6.

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.

de Wit M, Carvalho B, Delis-van Diemen PM, van Alphen C, Beliën JAM, Meijer GA, Fijneman RJA.

PLoS One. 2017 May 8;12(5):e0174768. doi: 10.1371/journal.pone.0174768. eCollection 2017.

7.

Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.

de Groen FL, Krijgsman O, Tijssen M, Vriend LE, Ylstra B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B.

Genes Chromosomes Cancer. 2014 Apr;53(4):339-48. doi: 10.1002/gcc.22144. Epub 2014 Jan 29.

PMID:
24478024
8.

Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.

Carvalho B, Sillars-Hardebol AH, Postma C, Mongera S, Terhaar Sive Droste J, Obulkasim A, van de Wiel M, van Criekinge W, Ylstra B, Fijneman RJ, Meijer GA.

Cell Oncol (Dordr). 2012 Feb;35(1):53-63. doi: 10.1007/s13402-011-0065-1. Epub 2012 Jan 26.

9.

Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression.

de Groen FL, Timmer LM, Menezes RX, Diosdado B, Hooijberg E, Meijer GA, Steenbergen RD, Carvalho B.

PLoS One. 2015 Jul 6;10(7):e0132495. doi: 10.1371/journal.pone.0132495. eCollection 2015.

10.

Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.

Alnabulsi A, Agouni A, Mitra S, Garcia-Murillas I, Carpenter B, Bird S, Murray GI.

J Pathol. 2012 Dec;228(4):471-81. doi: 10.1002/path.4031. Epub 2012 Aug 20.

PMID:
22450763
11.

Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas.

Zarzour P, Boelen L, Luciani F, Beck D, Sakthianandeswaren A, Mouradov D, Sieber OM, Hawkins NJ, Hesson LB, Ward RL, Wong JW.

Genes Chromosomes Cancer. 2015 May;54(5):303-14. doi: 10.1002/gcc.22243. Epub 2015 Feb 27.

PMID:
25726927
12.

Relationship of gene expression and chromosomal abnormalities in colorectal cancer.

Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald WL, Paty PB, Domany E, Notterman DA.

Cancer Res. 2006 Feb 15;66(4):2129-37.

13.

Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage.

Tai CJ, Su TC, Jiang MC, Chen HC, Shen SC, Lee WR, Liao CF, Chen YC, Lin SH, Li LT, Shen KH, Yeh CM, Yeh KT, Lee CH, Shih HY, Chang CC.

J Transl Med. 2013 Jan 31;11:29. doi: 10.1186/1479-5876-11-29.

14.

Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability.

Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W, De Goeij A, Meijer G.

Gastroenterology. 2002 Oct;123(4):1109-19.

PMID:
12360473
15.

Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.

Chell SD, Witherden IR, Dobson RR, Moorghen M, Herman AA, Qualtrough D, Williams AC, Paraskeva C.

Cancer Res. 2006 Mar 15;66(6):3106-13.

16.

Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.

Bahnassy AA, Zekri AR, Salem SE, Abou-Bakr AA, Sakr MA, Abdel-Samiaa AG, Al-Bradei M.

Histol Histopathol. 2014 Feb;29(2):207-16. doi: 10.14670/HH-29.207. Epub 2013 Sep 2.

PMID:
23996743
17.

Expression of putative stem cell genes Musashi-1 and beta1-integrin in human colorectal adenomas and adenocarcinomas.

Fan LF, Dong WG, Jiang CQ, Xia D, Liao F, Yu QF.

Int J Colorectal Dis. 2010 Jan;25(1):17-23. doi: 10.1007/s00384-009-0791-2. Epub 2009 Aug 29.

PMID:
19714342
18.

Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression.

Ruebel KH, Leontovich AA, Jin L, Stilling GA, Zhang H, Qian X, Nakamura N, Scheithauer BW, Kovacs K, Lloyd RV.

Endocrine. 2006 Jun;29(3):435-44.

PMID:
16943582
19.

Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence.

Xu J, Lü B, Xu F, Gu H, Fang Y, Huang Q, Lai M.

J Cancer Res Clin Oncol. 2008 Aug;134(8):891-8. doi: 10.1007/s00432-008-0353-y. Epub 2008 Feb 9.

PMID:
18264726
20.

The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.

Zheng HC, Xia P, Xu XY, Takahashi H, Takano Y.

Hum Pathol. 2011 Mar;42(3):424-33. doi: 10.1016/j.humpath.2009.12.018. Epub 2010 Dec 28.

PMID:
21193223

Supplemental Content

Support Center